- Home
- RNXT vs MKTW Comparison
RNXT vs MKTW Comparison
Compare RNXT & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNXT | MKTW |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 39.7M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RNXT | MKTW |
|---|---|---|
| Price | $0.89 | $16.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $8.25 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 311.0K | 25.6K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 10.20% |
| EPS Growth | 20.00 | ★ 1183.33 |
| EPS | ★ N/A | N/A |
| Revenue | $1,123,000.00 | ★ $512,403,000.00 |
| Revenue This Year | $194.66 | $1.52 |
| Revenue Next Year | $279.78 | $4.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $13.49 |
| 52 Week High | $1.45 | $21.74 |
Technical Indicators
Market Signals| Indicator | RNXT | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 44.89 |
| Support Level | $0.89 | $16.16 |
| Resistance Level | $1.07 | $16.65 |
| Average True Range (ATR) | 0.07 | 0.68 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 54.09 | 18.32 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms, including mobile, desktop, and tablets.